Johnson & Johnson shares slip as healthcare firm posts solid quarterly results

Johnson & Johnson shares slip as healthcare firm posts solid quarterly results

Johnson & Johnson’s JNJ.N shares were trading around $218.21, down about 0.2 percent intraday on Wednesday, extending recent modest weakness…

Earnings Summary: Highlights of Citizens Financial Group’s Q4 2025 report

Citizens Financial Group, Inc. (NYSE: CFG), a leading financial services company, on Wednesday announced financial results for the fourth quarter…

Earnings Summary: Prologis Q4 FY25 revenue rises modestly

Real estate investment trust Prologis, Inc. (NYSE: PLD) on Wednesday reported an increase in revenues and adjusted core funds from…

Earnings Summary: TE Connectivity (TEL) reports strong revenue and profit growth for Q1 FY26

TE Connectivity Ltd. (NYSE: TEL), which designs and manufactures connectivity and sensor solutions, on Wednesday reported a sharp increase in revenues…

Earnings: Charles Schwab Corporation Q4 2025 revenues rise 19%

Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Wednesday reported a double-digit growth in revenues for the fourth…

Earnings Summary: Highlights of KeyCorp’s (KEY) Q4 2025 report

KeyCorp (NYSE: KEY), a provider of retail and commercial banking services, announced financial results for the fourth quarter of fiscal…

Earnings Summary: A snapshot of 3M Company’s Q4 2025 results

3M Company (NYSE: MMM), a leading manufacturer and distributor of industrial products and solutions, on Tuesday announced financial results for…

Hancock Whitney Corp Shares Edge Lower After Latest Close

Hancock Whitney Corporation (NASDAQ: HWC) closed lower in the latest trading session, with the stock declining about 1% intraday as…

Earnings Summary: DR Horton reports lower revenue and profit for Q1 FY26

Homebuilder D.R. Horton, Inc. (NYSE: DHI) on Tuesday reported a year-over-year decline in revenues and earnings for the first quarter of…

Plus Therapeutics CEO On Radiopharmaceuticals

Marc Belsky, CEO of Plus Therapeutics, discusses advances in radiopharmaceutical treatments for cancer. On Technology Q: Can you explain Plus…